Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

186.95 -0.63 (-0.34%)
Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
UiPath is a Cheaper and More Profitable AI Stock
With the mainstream popularity of ChatGPT, artificial intelligence (AI) has been all the rage in 2023. The AI wars between Microsoft Co. (NASDAQ: MSFT) invest 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Analyst Expectations for Quest Diagnostics's Future ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023 ↗
 
Via Benzinga
News headline image
Analyst Expectations for Quest Diagnostics's Future ↗
 
Via Benzinga
5 Analysts Have This to Say About Quest Diagnostics ↗
 
Via Benzinga
News headline image
Analyst Ratings for Quest Diagnostics ↗
 
Via Benzinga
Where Quest Diagnostics Stands With Analysts ↗
 
Via Benzinga
Quest Diagnostics Inc. (NYSE: DGX) Making Surprising Moves in Friday Session
Via Investor Brand Network
News headline image
Is This Healthcare Stock a Buy for Dividend Growth Investors? ↗
This maker of diagnostics tests just announced that it will be sending more cash to its shareholders. 
Via The Motley Fool
News headline image
2 Dividend Stocks That Recently Boosted Their Payouts by More Than 7% ↗
These companies may not be finished raising their dividend payments as they both have low payout ratios. 
Via The Motley Fool
News headline image
Down 40% in 2022, Can Exact Sciences Recover in 2023? ↗
Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous. 
Via The Motley Fool
News headline image
These 2 Defensive Plays Are Highlights Of CNBC's 'Final Trades' ↗
On CNBC’s "Halftime Report: Final Trades," Shannon Saccocia of Boston Private said Quest Diagnostics Inc (NYSE: DGX) is expected to grow 4% to 5% 
Via Benzinga
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Golden Cross Appears Before Quest Diagnostics Investors ↗
 
Via Benzinga
Where Quest Diagnostics Stands With Analysts ↗
 
Via Benzinga
News headline image
Why Quest Diagnostics Stock Jumped Today ↗
Growth in the lab testing titan's core business is accelerating. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023 ↗
 
Via Benzinga
News headline image
Quest Diagnostics To Plunge 16%? Here Are 5 Other Price Target Changes For Thursday ↗
 
Via Benzinga
News headline image
Quest Diagnostics Q3 Earnings Surpass Expectations, Raises Annual Guidance ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022 ↗
Upgrades 
Via Benzinga
News headline image
DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test
From DermTech, Inc.
Via Business Wire
News headline image
Here’s Why Quest Diagnostics Stock Should Be in Your Portfolio
Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been trading within a boxed range from $126 to $146 for the majority of 2022. 
Via MarketBeat
News headline image
Quest Diagnostics: Q3 Earnings Insights ↗
Quest Diagnostics (NYSE:DGX) reported its Q3 earnings results on Thursday, October 20, 2022 at 06:45 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
A Preview Of Quest Diagnostics's Earnings ↗
Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2022-10-20. Here's what investors need to know before the announcement. Analysts estimate that Quest... 
Via Benzinga
News headline image
Eli Lilly, EQT, Cash Cows ETF, Northrop Grumman And This Diagnostics Company Feature On CNBC's Final Trade ↗
On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management said Pacer US Cash Cows 100 ETF (BATS: COWZ) is “a factor-b 
Via Benzinga
News headline image
What Fast Food And Entertainment Giants Did Traders Pick For CNBC's Fast Money Call Of The Day ↗
CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The information is collected and refined... 
Via Benzinga
News headline image
Earnings Scheduled For October 20, 2022 ↗
Companies Reporting Before The Bell • ABB (NYSE:ABB) is estimated to report quarterly earnings at $0.38 per share on revenue of $7.35 billion. 
Via Benzinga
News headline image
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests ↗
 
Via Benzinga
News headline image
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns ↗
The World Health Organization (WHO) warned that it struggles to identify and 
Via Benzinga
News headline image
Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Technology Awards
From Achievers
Via Business Wire
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.